27.11.2012 Views

BioWorld® - Medical Device Daily

BioWorld® - Medical Device Daily

BioWorld® - Medical Device Daily

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

BioWorld Industrial Biotechnology StatReport: Immediate and Comprehensive Industry Information<br />

PRODUCTS ON MARKET: Gonogen II (N. gonorrhoeae) diagnostic test reagents using Mab<br />

Bioluminescence test for human, food, environmental, biowarfare<br />

Trust--Syphilis detection test<br />

Smart II--diagnostic kit for E. coli and Salmonella<br />

STD tests: GonoGen II and TRUST<br />

Cholera test kits<br />

Environmental testing<br />

Profile-1 bioluminescence test for detection of food, water, environment and<br />

human-borne pathogens<br />

Biowarfare detection kits<br />

New Zealand Pharmaceuticals Ltd.<br />

P. O. Box 1869, 68 Weld Street<br />

Palmerston North 4440, New Zealand<br />

Phone: +64 6-952-3800; Fax: +64 6-952-3801<br />

Web: www.nzp.co.nz<br />

E-mail: market@nzp.co.nz<br />

KEY PERSONNEL: Dr. Richard Garland; Managing Director<br />

Andrew Lewis; General Manager<br />

Barry Old; Marketing and Technical Director<br />

Selwyn Yorke; Market Development Manager<br />

Michael Callagher; Commercial Manager<br />

EMPLOYEES: 98 employees<br />

HISTORY: Founded and began biotech R&D in 1971<br />

FACILITIES: Two pilot plants with a total area of 188 sq. m., one of which has explosion<br />

protected operations. Three factory and one more under construtcion.<br />

STOCK-FINANCIAL HISTORY: Privately held<br />

INVESTMENTS: Just the Berries Ltd.--joint venture between NZP Holdings Ltd. and Just the<br />

Berries Holdings Ltd. (2/03)<br />

BUSINESS STRATEGY: Manufacture plant and animal extracts for biotechnology, pharmaceutical<br />

and health food and cosmetics industries. Chemical synthesis of specialty<br />

carbohydrates and related compounds.<br />

PRODUCTS ON MARKET: Peptones, cholic acid, deoxycholic acid, dehydrocholic acid, taurocholate,<br />

glycocholate taurodeoxycholate, methyl cholate, bile salts, heparin, chiroinositol,<br />

chondroitin sulphate, ferritin, pinitol, galactasomine, and<br />

acetylmannosamine, mannosamine, sialic acid, actinidin, evening primrose<br />

polyphenolic antioxidants, actinidin, cartilage products.<br />

PRODUCTS IN DEVELOPMENT: Name Status<br />

Carbohydrates in pilot plant<br />

Blackcurrant extracts in pilot plant<br />

Nigu Bioselect<br />

Beuthener Strasse 2<br />

Waldkraiburg D-84478, Germany<br />

Phone: +49 86 38-962-0; Fax: +49 86 38-962-287<br />

Web: www.nigu.de<br />

E-mail: info@nigu.de<br />

KEY PERSONNEL: Dr. Klaus Engel; Chairman, Degussa<br />

Joachim Semel, Ph.D.; Managing Director, Nigu Chemie<br />

EMPLOYEES: 55 employees<br />

Copyright ©2006 AHC Media ® 274

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!